Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Haematologica|May 25, 2010
Fertility recovery and pregnancy after allogeneic hematopoietic stem cell transplantation in Fanconi anemia patientsSamir K Nabhan, Marco A Bitencourt, Michel Duval, et al.British Journal of Haematology|January 22, 2024
Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology GuidelineAustin Kulasekararaj, Jamie Cavenagh, Inderjeet Dokal, et al.Arthritis and Rheumatism|October 2, 2002
A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritisJohn Moore, Peter Brooks, Sam Milliken, et al.British Journal of Haematology|July 11, 2006
The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British Society of Blood and Marrow Transplantation studyJennifer M Bird, Rhian Fuge, Bhawna Sirohi, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 13, 2015
Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA TrialCharles Craddock, Nadira Jilani, Shamyla Siddique, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 27, 2024
Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosisTomas Kalincik, Sifat Sharmin, Izanne Roos, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 5, 2025
Real-world effectiveness of autologous haematopoietic stem cell transplantation for multiple sclerosis in the UKPaolo Antonio Muraro, Majid Kazmi, Eleonora De Matteis, et al.Blood|July 1, 2010
Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitutionRonjon Chakraverty, Guillermo Orti, Michael Roughton, et al.Journal of Clinical Apheresis|June 21, 2017
UK consensus statement on the use of plerixafor to facilitate autologous peripheral blood stem cell collection to support high-dose chemoradiotherapy for patients with malignancyKenneth W Douglas, Maria Gilleece, Patrick Hayden, et al.Haematologica|December 3, 2009
Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemiaCharles Craddock, Sandeep Nagra, Andrew Peniket, et al.Pageof 3